
OpenEvidence has secured 250 million dollars at a 12 billion dollar valuation, cementing its role as...
The AMW Read
The $12B valuation exceeds the cross.Β§D threshold and establishes OpenEvidence as a top-tier vertical leader, validating the 'Bio-platform bull' debate frame via massive scale.
OpenEvidence has secured 250 million dollars at a 12 billion dollar valuation, cementing its role as the primary AI infrastructure for U.S. healthcare. With 40 percent of domestic physicians already using the tool to manage 100 million patient consultations, the platform effectively solves the critical medical information overload crisis. By utilizing a conductor AI to route queries to specialized sub-specialty models, it achieves clinical accuracy that general models cannot match. This milestone signals a systemic shift toward specialized medical superintelligence as an essential daily utility for global patient safety. π©Ίπ


